{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:01:44Z","timestamp":1792810904435,"version":"4.5.0"},"reference-count":280,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejca.2026.116763","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:31:57Z","timestamp":1778167917000},"page":"116763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention \u2013 Update 2026"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4989-9075","authenticated-orcid":false,"given":"Alexander J.","family":"Stratigos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4832-3410","authenticated-orcid":false,"given":"Clio","family":"Dessinioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Lebbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Bataille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5574-5825","authenticated-orcid":false,"given":"Brigitte","family":"Dreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2279-6906","authenticated-orcid":false,"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1007-7883","authenticated-orcid":false,"given":"Ana Maria","family":"Forsea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7090-9584","authenticated-orcid":false,"given":"Christoffer","family":"Gebhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hauschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1192-0227","authenticated-orcid":false,"given":"Christoph","family":"Hoeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidija","family":"Kandolf-Sekulovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole WJ","family":"Kelleners-Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5897-2780","authenticated-orcid":false,"given":"Peter","family":"Koelblinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7193-0964","authenticated-orcid":false,"given":"Aimilios","family":"Lallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9566-8238","authenticated-orcid":false,"given":"Konstantinos","family":"Liopyris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"del Marmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moreno-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pellacani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6500-3507","authenticated-orcid":false,"given":"Philippe","family":"Saiag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrto","family":"Trakatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Zalaudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Arenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.J.","family":"van Akkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.M.","family":"Eggermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lorigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8846-8959","authenticated-orcid":false,"given":"Mario","family":"Mandala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116763_bib1","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib2","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib3","unstructured":"Bordeaux J., Nghiem P., Aasi S.Z., Alam M., Amini A., Bolotin D., et al. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Squamous cell skin cancer. Version 1.2026. Available at: \u3008https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/squamous.pdf\u3009. Accessed on October 8, 2025. 2026."},{"key":"10.1016\/j.ejca.2026.116763_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bjd.19621","article-title":"British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020","volume":"184","author":"Keohane","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib5","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.ejca.2026.116763_bib6","unstructured":"Howick J., Chalmers I., Glasziou P., Greenhalgh T., Heneghan C., Liberati A., et al. The Oxford Levels of Evidence 2 Available at: \u3008https:\/\/wwwcebmoxacuk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence\u3009 Accessed on July 17, 2022: Oxford Center for Evifdence-Based Medicine."},{"key":"10.1016\/j.ejca.2026.116763_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamadermatol.2022.5508","article-title":"Association of Patient Risk Factors, Tumor Characteristics, and Treatment Modality With Poor Outcomes in Primary Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-analysis","volume":"159","author":"Zakhem","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.116763_bib10","series-title":"TNM Classification of malignant tumours","author":"Union for International Cancer Control","year":"2017"},{"key":"10.1016\/j.ejca.2026.116763_bib11","author":"AJCC Cancer Staging Manual","year":"2017"},{"key":"10.1016\/j.ejca.2026.116763_bib12","series-title":"Union for International Cancer Control (UICC) TNM Classification of Malignant Tumours","author":"Skin Tumours","year":"2025"},{"key":"10.1016\/j.ejca.2026.116763_bib13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/jdv.20209","article-title":"Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts","volume":"39","author":"Gaudy-Marqueste","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjd.15324","article-title":"Cutaneous squamous cell carcinoma: an epidemiological review","volume":"177","author":"Green","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2023.01.017","article-title":"Incidence, mortality and trends of cutaneous squamous cell carcinoma in Germany, the Netherlands, and Scotland","volume":"183","author":"Keim","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib16","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.jid.2017.04.020","article-title":"Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany","volume":"137","author":"Leiter","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16030606","article-title":"Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma","volume":"16","author":"Nanz","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejca.2026.116763_bib18","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/bjd.19879","article-title":"Invasive and in situ squamous cell carcinoma of the skin: a nationwide study in Iceland","volume":"185","author":"Adalsteinsson","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bjd.12988","article-title":"Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention","volume":"171","author":"Deady","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.17873","article-title":"Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study","volume":"181","author":"Venables","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/cam4.404","article-title":"Cutaneous squamous cell carcinoma in Norway 1963-2011: increasing incidence and stable mortality","volume":"4","author":"Robsahm","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2026.116763_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5694\/mja17.00284","article-title":"The incidence and multiplicity rates of keratinocyte cancers in Australia","volume":"207","author":"Pandeya","year":"2017","journal-title":"Med J Aust"},{"key":"10.1016\/j.ejca.2026.116763_bib23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamadermatol.2025.1276","article-title":"Burden of Skin Cancer in Older Adults From 1990 to 2021 and Modelled Projection to 2050","volume":"161","author":"Wang","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib24","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/bjd.15110","article-title":"Predicted cases of U.K. skin squamous cell carcinoma and basal cell carcinoma in 2020 and 2025: horizon planning for National Health Service dermatology and dermatopathology","volume":"176","author":"Goon","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib25","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jaad.2020.06.1024","article-title":"Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma among patients with chronic lymphocytic leukemia","volume":"83","author":"Kleinstern","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.ejca.2026.116763_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/jdv.16025","article-title":"Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC","volume":"33","author":"Plasmeijer","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib28","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jaad.2024.01.040","volume":"90","author":"de Jong","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jaad.2014.10.028","article-title":"Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota","volume":"72","author":"Brewer","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib30","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/bjd\/ljaf027","article-title":"Skin cancer risk in more than 200 000 patients with haematological malignancies over 30 years: a nationwide population-based study in the Netherlands","volume":"192","author":"Eggermont","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258423","article-title":"network RO-S. Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study","volume":"16","author":"Cardoso Borges","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.ejca.2026.116763_bib32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/ijd.15813","article-title":"Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia: a systematic review of the literature","volume":"61","author":"Lai","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaad.2018.03.024","article-title":"Risk of skin cancer in patients with HIV: A Danish nationwide cohort study","volume":"79","author":"Omland","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jdv.17709","article-title":"Epidemiology of advanced cutaneous squamous cell carcinoma","volume":"36","author":"Dessinioti","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/bjd.14352","article-title":"Survival with nonmelanoma skin cancer in Germany","volume":"174","author":"Eisemann","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaad.2021.09.067","article-title":"Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma: A nationwide cancer registry study","volume":"86","author":"Tokez","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamadermatol.2018.4219","article-title":"Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England","volume":"155","author":"Venables","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/jso.23155","article-title":"The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors","volume":"106","author":"Brougham","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2026.116763_bib39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2026.116763_bib40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/jamadermatol.2025.0128","article-title":"Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell Carcinoma","volume":"161","author":"Ran","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib42","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.jid.2017.06.025","article-title":"Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study","volume":"137","author":"Eigentler","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib43","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/cncr.30601","article-title":"A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck","volume":"123","author":"Manyam","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hed.23283","article-title":"Cancer of the head and neck region in solid organ transplant recipients","volume":"36","author":"Rabinovics","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2026.116763_bib45","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1159\/000524460","article-title":"A Sensitivity Meta-Analysis of Disease-Specific Death in Localized Cutaneous Squamous Cell Carcinoma","volume":"238","author":"Dessinioti","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.ejca.2026.116763_bib46","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jamaoto.2018.4515","article-title":"Outcomes of Cutaneous Squamous Cell Carcinoma in the Head and Neck Region With Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis","volume":"145","author":"Sahovaler","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib47","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hed.25069","article-title":"Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion","volume":"40","author":"Lam","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2026.116763_bib48","doi-asserted-by":"crossref","first-page":"adv00523","DOI":"10.2340\/00015555-3875","article-title":"Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study","volume":"101","author":"Robertson","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jamadermatol.2018.1118","article-title":"Prevalence of Skin Cancer Examination Among Users of Indoor Tanning Beds","volume":"154","author":"Morris","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17101702","article-title":"Current and Emerging Insights into the Causes, Immunopathogenesis, and Treatment of Cutaneous Squamous Cell Carcinoma","volume":"17","author":"Anderson","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejca.2026.116763_bib51","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41568-023-00583-5","article-title":"Advances in cutaneous squamous cell carcinoma","volume":"23","author":"Winge","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib52","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/bjd.15932","article-title":"Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma","volume":"177","author":"Harwood","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib53","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00403-024-03109-7","article-title":"A retrospective analysis of drugs associated with the development of cutaneous squamous cell carcinoma reported by patients on the FDA's adverse events reporting system","volume":"316","author":"Jean-Pierre","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ejca.2026.116763_bib54","doi-asserted-by":"crossref","first-page":"83280","DOI":"10.18632\/oncotarget.21059","article-title":"Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF\/MEK inhibitors in cancer patients: a meta-analysis","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2026.116763_bib55","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1038\/s41598-018-23439-7","article-title":"Voriconazole-induced photocarcinogenesis is promoted by aryl hydrocarbon receptor-dependent COX-2 upregulation","volume":"8","author":"Ikeya","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2026.116763_bib56","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00228-022-03299-x","article-title":"Hydrochlorothiazide use is associated with the risk of cutaneous and lip squamous cell carcinoma: A systematic review and meta-analysis","volume":"78","author":"de Macedo Andrade","year":"2022","journal-title":"Eur J Clin Pharm"},{"key":"10.1016\/j.ejca.2026.116763_bib57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/bjd.19880","article-title":"Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group","volume":"185","author":"Schneider","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib58","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1158\/1078-0432.CCR-18-1122","article-title":"Keratinocyte Carcinomas: Current Concepts and Future Research Priorities","volume":"25","author":"Nagarajan","year":"2019","journal-title":"Clinical cancer research official journal American Association Cancer Research"},{"key":"10.1016\/j.ejca.2026.116763_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006783","article-title":"Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice","volume":"14","author":"Viarisio","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ejca.2026.116763_bib60","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41586-019-1719-9","article-title":"Immunity to commensal papillomaviruses protects against skin cancer","volume":"575","author":"Strickley","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2026.116763_bib61","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41416-018-0105-y","article-title":"Heterogeneous relationships of squamous and basal cell carcinomas of the skin with smoking: the UK Million Women Study and meta-analysis of prospective studies","volume":"119","author":"Pirie","year":"2018","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2026.116763_bib62","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jid.2017.03.027","article-title":"Cigarette Smoking and the Risks of Basal Cell Carcinoma and Squamous Cell Carcinoma","volume":"137","author":"Dusingize","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib63","article-title":"Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC)","author":"Mahamat-Saleh","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib64","article-title":"Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma","volume":"7","author":"Chahal","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116763_bib65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jid.2017.09.034","article-title":"Susceptibility Loci-Associated Cutaneous Squamous Cell Carcinoma Invasiveness","volume":"138","author":"Wang","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib66","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1038\/s41467-018-06149-6","article-title":"Gene expression imputation identifies candidate genes and susceptibility loci associated with cutaneous squamous cell carcinoma","volume":"9","author":"Ioannidis","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116763_bib67","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jid.2018.01.031","article-title":"Quantifying the Polygenic Contribution to Cutaneous Squamous Cell Carcinoma Risk","volume":"138","author":"Sordillo","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib68","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41467-020-14594-5","article-title":"Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma","volume":"11","author":"Sarin","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116763_bib69","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma","volume":"1","author":"Marks","year":"1988","journal-title":"Lancet (Lond Engl)"},{"key":"10.1016\/j.ejca.2026.116763_bib70","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: a systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib71","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1038\/jid.2014.154","article-title":"NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis","volume":"134","author":"South","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib72","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116763_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12601","article-title":"Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates","volume":"7","author":"Chitsazzadeh","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116763_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12493","article-title":"Inactivation of TGFbeta receptors in stem cells drives cutaneous squamous cell carcinoma","volume":"7","author":"Cammareri","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116763_bib75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cncr.29738","article-title":"Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies","volume":"122","author":"Al-Rohil","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib76","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41525-021-00226-4","article-title":"The landscape of driver mutations in cutaneous squamous cell carcinoma","volume":"6","author":"Chang","year":"2021","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.ejca.2026.116763_bib77","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jid.2021.07.172","article-title":"Genomic Progression of Precancerous Actinic Keratosis to Squamous Cell Carcinoma","volume":"142","author":"Kim","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib78","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jid.2020.12.024","article-title":"The Genomic Landscape of Actinic Keratosis","volume":"141","author":"Thomson","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib79","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jid.2020.05.116","article-title":"Whole-Exome and Transcriptome Analysis of UV-Exposed Epidermis and Carcinoma In Situ Reveals Early Drivers of Carcinogenesis","volume":"141","author":"Zheng","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib80","first-page":"10","article-title":"APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa","author":"Cho","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ejca.2026.116763_bib81","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jid.2023.11.025","article-title":"Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa-Associated Cutaneous Squamous Cell Carcinoma","volume":"144","author":"Lee","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib82","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1038\/s41467-023-40822-9","article-title":"Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression","volume":"14","author":"Bailey","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116763_bib83","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/bjd\/ljaf108","article-title":"The landscape of long noncoding RNA during cutaneous squamous cell carcinoma progression","volume":"193","author":"Bone","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223341","article-title":"Genome wide DNA methylation profiling identifies specific epigenetic features in high-risk cutaneous squamous cell carcinoma","volume":"14","author":"Hervas-Marin","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.ejca.2026.116763_bib85","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41467-018-03025-1","article-title":"Methylation profiling identifies two subclasses of squamous cell carcinoma related to distinct cells of origin","volume":"9","author":"Rodriguez-Paredes","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116763_bib86","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cell.2020.05.039","article-title":"Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma","volume":"182","author":"Ji","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2026.116763_bib87","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/DAD.0000000000001164","article-title":"PD-L1 Expression is Increased in Metastasizing Squamous Cell Carcinomas and Their Metastases","volume":"40","author":"Garcia-Diez","year":"2018","journal-title":"Am J Derm"},{"key":"10.1016\/j.ejca.2026.116763_bib88","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/bjd.14955","article-title":"The pattern and clinicopathological correlates of programmed death-ligand 1 expression in cutaneous squamous cell carcinoma","volume":"176","author":"Schaper","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib89","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-22-1332","article-title":"High-Dimensional and Spatial Analysis Reveals Immune Landscape-Dependent Progression in Cutaneous Squamous Cell Carcinoma","volume":"28","author":"Ferguson","year":"2022","journal-title":"Clinical cancer research official journal American Association Cancer Research"},{"key":"10.1016\/j.ejca.2026.116763_bib90","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-025-09370-8","article-title":"Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy","volume":"646","author":"Baruch","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2026.116763_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2022.03.017","article-title":"Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma","author":"Voigt","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1091379","article-title":"Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: Outlook for future therapies?","volume":"13","author":"Bromfield","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2026.116763_bib93","series-title":"WHO Classification of Tumours, Skin Tumours WHO Classification of Tumours Editorial","first-page":"78","article-title":"Zalaudek I. Keratoacanthoma","author":"Carr","year":"2025"},{"key":"10.1016\/j.ejca.2026.116763_bib94","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archdermatol.2012.2974","article-title":"Dermoscopy of squamous cell carcinoma and keratoacanthoma","volume":"148","author":"Rosendahl","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib95","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/bjd.13510","article-title":"The clinical and dermoscopic features of invasive cutaneous squamous cell carcinoma depend on the histopathological grade of differentiation","volume":"172","author":"Lallas","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib96","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaad.2011.02.011","article-title":"Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model","volume":"66","author":"Zalaudek","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib97","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1093\/ced\/llaf255","article-title":"How do we recognize a difficult squamous cell carcinoma? A retrospective analysis of clinically and dermoscopically misdiagnosed tumours","volume":"50","author":"Korecka","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib98","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2021.03.111","article-title":"Evaluation of dermatoscopic criteria for early detection of squamous cell carcinoma arising on an actinic keratosis","volume":"86","author":"Papageorgiou","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib99","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jaad.2020.02.019","article-title":"Accuracy of dermoscopic criteria for the differential diagnosis between irritated seborrheic keratosis and squamous cell carcinoma","volume":"85","author":"Papageorgiou","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib100","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archdermatol.2009.134","article-title":"Reflectance confocal microscopy criteria for squamous cell carcinomas and actinic keratoses","volume":"145","author":"Rishpon","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib101","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/jdv.14463","article-title":"Dermoscopic and reflectance confocal microscopy features of cutaneous squamous cell carcinoma","volume":"31","author":"Manfredini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib102","article-title":"Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults","volume":"12","author":"Dinnes","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2026.116763_bib103","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1111\/jdv.17603","article-title":"Line-field confocal optical coherence tomography for the in vivo real-time diagnosis of different stages of keratinocyte skin cancer: a preliminary study. J Eur","volume":"35","author":"Ruini","year":"2021","journal-title":"Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib104","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/jdv.12954","article-title":"High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma","volume":"29","author":"Boone","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib105","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/jdv.14335","article-title":"vivo microvascular imaging of cutaneous actinic keratosis, Bowen's disease and squamous cell carcinoma using dynamic optical coherence tomography","volume":"31","author":"Themstrup","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.ejca.2026.116763_bib106","article-title":"Optical coherence tomography for diagnosing skin cancer in adults","author":"Ferrante di Ruffano","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2026.116763_bib107","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamadermatol.2017.4506","article-title":"Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients","volume":"154","author":"Cheng","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib108","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/ijd.12553","article-title":"Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends","volume":"54","author":"Kallini","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib109","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-2559.2000.00999.x","article-title":"Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin","volume":"37","author":"Beer","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2026.116763_bib111","series-title":"WHO Classification of Skin Tumours","first-page":"35","article-title":"Squamous cell carcinoma","author":"Murphy","year":"2018"},{"key":"10.1016\/j.ejca.2026.116763_bib112","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/(SICI)1097-0142(19970301)79:5<915::AID-CNCR7>3.0.CO;2-A","article-title":"Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer","volume":"79","author":"Breuninger","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib113","series-title":"AJCC Cancer Staging Manual","first-page":"171","article-title":"Cutaneous Carcinoma of the Head and Neck","author":"Califano","year":"2017"},{"key":"10.1016\/j.ejca.2026.116763_bib114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamadermatol.2013.746","article-title":"Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study","volume":"149","author":"Carter","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib115","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.jid.2020.01.035","article-title":"Prognostic Impact of Perineural Invasion in Cutaneous Squamous Cell Carcinoma: Results of a Prospective Study of 1,399 Tumors","volume":"140","author":"Haug","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib116","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/DSS.0000000000003324","article-title":"Local Tumor Infiltration and Locoregional Recurrence in Desmoplastic Cutaneous Squamous Cell Carcinoma","volume":"48","author":"Kofler","year":"2022","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143556","article-title":"Recent Advances in the Diagnosis and Management of High-Risk Cutaneous Squamous Cell Carcinoma","volume":"14","author":"Dessinioti","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejca.2026.116763_bib118","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jdv.17531","article-title":"Overview of guideline recommendations for the management of high-risk and advanced cutaneous squamous cell carcinoma","volume":"36","author":"Dessinioti","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib119","first-page":"268","article-title":"Prognostic factors for metastasis in squamous cell carcinoma of the skin","volume":"28","author":"Cherpelis","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib120","first-page":"37","article-title":"Squamous cell carcinoma of the skin--histopathological features and their significance for the clinical outcome","volume":"11","author":"Petter","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib121","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s10147-020-01830-7","article-title":"Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients","volume":"26","author":"Saito","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116763_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2022.02.056","article-title":"Risk factors for metastatic cutaneous squamous cell carcinoma: Refinement and replication based on 2 nationwide nested case-control studies","author":"Tokez","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib123","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.21250","article-title":"Risk factors for distant metastasis in cutaneous squamous cell carcinoma","author":"Stefanovic","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib124","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jaad.2021.11.002","article-title":"Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion","volume":"86","author":"Kus","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2022.08.050","article-title":"Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual center retrospective cohort analysis of primary N0 disease","author":"O'Connor","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib126","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jamadermatol.2023.3703","article-title":"Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis","volume":"159","author":"Massey","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib127","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jaad.2025.04.029","article-title":"Lymphovascular invasion is an independent predictor of metastasis and disease-specific death in cutaneous squamous cell carcinoma: A multicenter retrospective study","volume":"93","author":"Hirotsu","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib128","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaad.2018.09.015","article-title":"Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone","volume":"80","author":"Marrazzo","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.ejca.2026.116763_bib129","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jamadermatol.2017.1680","article-title":"Clinical and Incidental Perineural Invasion of Cutaneous Squamous Cell Carcinoma: A Systematic Review and Pooled Analysis of Outcomes Data","volume":"153","author":"Karia","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib130","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/DSS.0000000000003553","article-title":"Squamous Cell Carcinoma With Bone Invasion: A Systematic Review and Pooled Survival Analysis","volume":"48","author":"Russell","year":"2022","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib131","article-title":"Impact of immunosuppression on cutaneous squamous cell carcinoma outcomes","author":"Klein","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib132","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/DSS.0000000000004680","article-title":"Immunosuppression as an Independent Risk Factor for Poor Outcomes in Cutaneous Squamous Cell Carcinoma: A Prospective Study","volume":"51","author":"Rosenthal","year":"2025","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib133","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000542772","article-title":"Perineural Invasion for Risk Stratification in Cutaneous Squamous Cell Carcinoma: A Scoping Review","volume":"241","author":"Cruts","year":"2025","journal-title":"Dermatology"},{"key":"10.1016\/j.ejca.2026.116763_bib134","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2022.05.043","article-title":"What causes the death of patients with cutaneous squamous cell carcinoma? A prospective analysis in 1400 patients","volume":"172","author":"Eigentler","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib135","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamadermatol.2023.1353","article-title":"Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma","volume":"159","author":"Stevens","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib136","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jaad.2024.11.082","article-title":"Prevalence of poor outcomes in cutaneous squamous cell carcinoma by AJCC and BWH tumor stages: A systematic review and meta-analysis","volume":"92","author":"Zakhem","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib137","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaad.2025.02.076","article-title":"riSCC: A personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinoma","volume":"93","author":"Jambusaria-Pahlajani","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102150","article-title":"Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model","volume":"63","author":"Rentroia-Pacheco","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejca.2026.116763_bib139","doi-asserted-by":"crossref","first-page":"9876","DOI":"10.1038\/s41598-022-13696-y","article-title":"Identification of metastatic primary cutaneous squamous cell carcinoma utilizing artificial intelligence analysis of whole slide images","volume":"12","author":"Knuutila","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2026.116763_bib140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41746-025-01496-3","article-title":"Self supervised artificial intelligence predicts poor outcome from primary cutaneous squamous cell carcinoma at diagnosis","volume":"8","author":"Coudray","year":"2025","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.ejca.2026.116763_bib141","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaad.2020.04.088","article-title":"Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma","volume":"84","author":"Wysong","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib142","article-title":"Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test","author":"Ibrahim","year":"2021","journal-title":"Future Oncol (Lond Engl)"},{"key":"10.1016\/j.ejca.2026.116763_bib143","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s13555-024-01111-5","article-title":"Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients","volume":"14","author":"Wysong","year":"2024","journal-title":"Dermatol Ther (Heide)"},{"key":"10.1016\/j.ejca.2026.116763_bib144","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ijrobp.2024.05.022","article-title":"Association of a 40-Gene Expression Profile With Risk of Metastatic Disease Progression of Cutaneous Squamous Cell Carcinoma and Specification of Benefit of Adjuvant Radiation Therapy","volume":"120","author":"Arron","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2026.116763_bib145","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1080\/14796694.2024.2390820","article-title":"Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profile","volume":"20","author":"Ruiz","year":"2024","journal-title":"Future Oncol (Lond Engl)"},{"key":"10.1016\/j.ejca.2026.116763_bib146","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s13555-024-01125-z","article-title":"Inconsistent Associations Between Risk Factor Profiles and Adjuvant Radiation Therapy (ART) Treatment in Patients with Cutaneous Squamous Cell Carcinoma and Utility of the 40-Gene Expression Profile to Refine ART Guidance","volume":"14","author":"Moody","year":"2024","journal-title":"Dermatol Ther (Heide)"},{"key":"10.1016\/j.ejca.2026.116763_bib147","first-page":"41","article-title":"Use of the 40-gene Expression Profile (40-GEP) Test in Medicare-eligible Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) to Guide Adjuvant Radiation Therapy (ART) Decisions Leads to a Significant Reduction in Healthcare Costs","volume":"17","author":"Somani","year":"2024","journal-title":"J Clin aesthetic Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15092456","article-title":"The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis","volume":"15","author":"Masarwy","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejca.2026.116763_bib149","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/lio2.724","article-title":"Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma","volume":"7","author":"Arron","year":"2022","journal-title":"Laryngoscope Invest Otolaryngol"},{"key":"10.1016\/j.ejca.2026.116763_bib150","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaad.2024.05.014","article-title":"Limitations of the commercially available gene expression test in predicting cutaneous squamous cell carcinoma metastasis and clinical outcomes","volume":"93","author":"Sax","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib151","doi-asserted-by":"crossref","first-page":"adv00143","DOI":"10.2340\/00015555-3498","article-title":"Update of the Management of Cutaneous Squamous-cell Carcinoma","volume":"100","author":"Maubec","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib152","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jaad.2018.09.006","article-title":"Nodal staging of high-risk cutaneous squamous cell carcinoma","volume":"81","author":"Fox","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib153","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bjoms.2014.01.015","article-title":"Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma","volume":"52","author":"Gurney","year":"2014","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib154","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejrad.2007.02.037","article-title":"Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging","volume":"64","author":"de Bondt","year":"2007","journal-title":"Eur J Radio"},{"key":"10.1016\/j.ejca.2026.116763_bib155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/ijgc-00009577-200601000-00050","article-title":"Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva","volume":"16","author":"Land","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib156","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jaad.2019.10.067","article-title":"Detection of subclinical disease with baseline and surveillance imaging in high-risk cutaneous squamous cell carcinomas","volume":"82","author":"Maher","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib157","article-title":"Assessment of the Diagnostic Accuracy of Baseline Clinical Examination and Ultrasonographic Imaging for the Detection of Lymph Node Metastasis in Patients With High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck","author":"Tokez","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib158","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jaad.2015.10.009","article-title":"The role of imaging in the management of patients with nonmelanoma skin cancer: When is imaging necessary?","volume":"76","author":"Humphreys","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib159","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0360-3016(00)01407-3","article-title":"Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis","volume":"49","author":"Williams","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2026.116763_bib160","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jaad.2015.10.010","article-title":"The role of imaging in the management of patients with nonmelanoma skin cancer: Diagnostic modalities and applications","volume":"76","author":"MacFarlane","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib161","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2016.08.051","article-title":"The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management","volume":"76","author":"Ruiz","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib162","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaad.2025.04.028","article-title":"Radiologic imaging aids management of high-risk cutaneous squamous cell carcinoma: A retrospective cohort study","volume":"93","author":"Wei","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib163","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/hed.23982","article-title":"Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma","volume":"38","author":"Warren","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2026.116763_bib164","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/hed.21470","article-title":"Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: comparing \"targeted\" MRI with the histologic findings following surgery","volume":"33","author":"Gandhi","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2026.116763_bib165","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/hed.21986","article-title":"Surgical resection for clinical perineural invasion from cutaneous squamous cell carcinoma of the head and neck","volume":"34","author":"Panizza","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2026.116763_bib166","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaad.2023.01.012","article-title":"Perioperative imaging for high-stage cutaneous squamous cell carcinoma helps guide management in nearly a third of cases: A single-institution retrospective cohort","volume":"88","author":"Gibson","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib167","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaad.2015.03.039","article-title":"High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: A literature review","volume":"73","author":"Navarrete-Dechent","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib168","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/1346-8138.14342","article-title":"Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma","volume":"45","author":"Tejera-Vaquerizo","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib169","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamadermatol.2013.6675","article-title":"Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system","volume":"150","author":"Schmitt","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244279","article-title":"Sentinel Lymph Node Biopsy: Is There a Role in Non-Melanoma Skin Cancer? A Systematic Review","volume":"16","author":"Borgognoni","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejca.2026.116763_bib171","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/jdv.20051","article-title":"Sentinel lymph node biopsy versus observation in high-risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study","volume":"38","author":"Tejera-Vaquerizo","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib172","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00403-024-02870-z","article-title":"Sentinel lymph node biopsy versus observation in high risk cutaneous squamous cell carcinoma of head and neck: a propensity score matching analysis","volume":"316","author":"Zhang","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ejca.2026.116763_bib173","article-title":"Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma","author":"Kesmodel","year":"2025","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib174","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1245\/s10434-023-13306-9","article-title":"Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma","volume":"30","author":"Huis In 't Veld","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2026.116763_bib175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jss.2019.03.040","article-title":"Cost-Effectiveness of Sentinel Lymph Node Biopsy for Head and Neck Cutaneous Squamous Cell Carcinoma","volume":"241","author":"Quinn","year":"2019","journal-title":"J Surg Res"},{"key":"10.1016\/j.ejca.2026.116763_bib176","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2340\/00015555-2942","article-title":"Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Series of 37 Cases and Systematic Review of the Literature","volume":"98","author":"Lhote","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib177","first-page":"1309","article-title":"Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature","volume":"32","author":"Ross","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib178","doi-asserted-by":"crossref","DOI":"10.1002\/hed.27121","article-title":"Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma of the head and neck: Systematic review and meta-analysis","author":"Costantino","year":"2022","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2026.116763_bib179","first-page":"118","article-title":"Diagnosis of invasive cutaneous squamous cell carcinoma, imaging and staging","volume":"159","author":"Dessinioti","year":"2024","journal-title":"Ital J Dermatol Venerol"},{"key":"10.1016\/j.ejca.2026.116763_bib180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib181","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/cncr.24855","article-title":"N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian","volume":"116","author":"Forest","year":"2010","journal-title":"Cancer Cent Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib182","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/cncr.24208","article-title":"Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival","volume":"115","author":"Oddone","year":"2009","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2026.116763_bib183","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamadermatol.2022.0001","article-title":"Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems","volume":"158","author":"Smile","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2025.07.029","article-title":"Satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: Risk factors and the prognostic significance","author":"Pahalyants","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib185","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2019.0032","article-title":"Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma","volume":"155","author":"Ruiz","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib186","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjd.20909","article-title":"Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data","volume":"186","author":"Venables","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib187","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamadermatol.2017.6428","article-title":"Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study","volume":"154","author":"Roscher","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib188","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1002\/hed.28259","article-title":"Validation of Current Staging Systems in HNCSCC: A Multinational Cohort Study","volume":"47","author":"Girardi","year":"2025","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2026.116763_bib189","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40257-025-00987-z","article-title":"Performance of staging systems for non-head and neck cutaneous squamous cell carcinoma","volume":"27","author":"Voller","year":"2026","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib190","first-page":"279","article-title":"The current burden of non-melanoma skin cancer attributable to ultraviolet radiation and related risk behaviours in Canada","volume":"32","author":"O'Sullivan","year":"2021","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejca.2026.116763_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114074","article-title":"Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them","volume":"204","author":"Garbe","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib192","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/0278-6133.25.1.34","article-title":"Evaluation of a multicomponent appearance-based sun-protective intervention for young women: uncovering the mechanisms of program efficacy","volume":"25","author":"Jackson","year":"2006","journal-title":"Health Psychol"},{"key":"10.1016\/j.ejca.2026.116763_bib193","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.amepre.2016.03.020","article-title":"Community-wide Interventions to Prevent Skin Cancer: Two Community Guide Systematic Reviews","volume":"51","author":"Sandhu","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ejca.2026.116763_bib194","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.2017.21630","article-title":"Behavioral Counseling for Skin Cancer Prevention: Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"319","author":"Henrikson","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2026.116763_bib195","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1080\/10810730.2013.778361","article-title":"Randomized trial of tailored skin cancer prevention for children: the Project SCAPE family study","volume":"18","author":"Glanz","year":"2013","journal-title":"J Health Commun"},{"key":"10.1016\/j.ejca.2026.116763_bib196","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ypmed.2014.12.009","article-title":"Can skin cancer prevention and early detection be improved via mobile phone text messaging? A randomised, attention control trial","volume":"71","author":"Youl","year":"2015","journal-title":"Prev Med"},{"key":"10.1016\/j.ejca.2026.116763_bib197","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(98)12168-2","article-title":"Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial","volume":"354","author":"Green","year":"1999","journal-title":"Lancet (Lond Engl)"},{"key":"10.1016\/j.ejca.2026.116763_bib198","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1158\/1055-9965.EPI-06-0352","article-title":"Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use","volume":"15","author":"van der Pols","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ejca.2026.116763_bib199","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJM199310143291602","article-title":"Reduction of solar keratoses by regular sunscreen use","volume":"329","author":"Thompson","year":"1993","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejca.2026.116763_bib200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2133.2009.09453.x","article-title":"Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study","volume":"161","author":"Ulrich","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib201","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1684\/ejd.2018.3251","article-title":"Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis","volume":"28","author":"Silva","year":"2018","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib202","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/ijc.31997","article-title":"Challenges in assessing the sunscreen-melanoma association","volume":"144","author":"Rueegg","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib203","first-page":"875","article-title":"New developments in occupational dermatology","volume":"14","author":"Diepgen","year":"2016","journal-title":"J der Dtsch Dermatol Ges = J Ger Soc Dermatol JDDG"},{"key":"10.1016\/j.ejca.2026.116763_bib204","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/HP.0b013e3181d85908","article-title":"ICNIRP statement--Protection of workers against ultraviolet radiation","volume":"99","author":"International Commission on Non-Ionizing Radiation P","year":"2010","journal-title":"Health Phys"},{"key":"10.1016\/j.ejca.2026.116763_bib205","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.seminoncol.2016.02.019","article-title":"Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment","volume":"43","author":"Kim","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejca.2026.116763_bib206","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-6143.2012.04292.x","article-title":"A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population","volume":"13","author":"Harwood","year":"2013","journal-title":"Am J Transpl J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib207","first-page":"422","article-title":"Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: a systematic review","volume":"27","author":"Saraiya","year":"2004","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ejca.2026.116763_bib208","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ypmed.2005.11.007","article-title":"A randomized intervention study of sun protection promotion in well-child care","volume":"42","author":"Crane","year":"2006","journal-title":"Prev Med"},{"key":"10.1016\/j.ejca.2026.116763_bib209","first-page":"500","article-title":"R. The sun sense study: an intervention to improve sun protection in children","volume":"34","author":"Shaheen","year":"2010","journal-title":"Am J Health Behav"},{"key":"10.1016\/j.ejca.2026.116763_bib210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archpedi.161.2.146","article-title":"A randomized trial of a multicomponent intervention for adolescent sun protection behaviors","volume":"161","author":"Norman","year":"2007","journal-title":"Arch Pedia Adolesc Med"},{"key":"10.1016\/j.ejca.2026.116763_bib211","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.det.2019.02.004","article-title":"Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer","volume":"37","author":"Nemer","year":"2019","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ejca.2026.116763_bib212","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.jid.5701058","article-title":"UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide","volume":"128","author":"Damian","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib213","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/12034754221078201","article-title":"Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis","volume":"26","author":"Mainville","year":"2022","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib214","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.116763_bib215","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2025.3238","article-title":"Nicotinamide for Skin Cancer Chemoprevention","author":"Breglio","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib216","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1002\/cncr.26374","article-title":"Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251)","volume":"118","author":"Kadakia","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib217","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1067\/S0190-9622(03)01587-1","article-title":"Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study","volume":"49","author":"Nijsten","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib218","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/bjd.12519","article-title":"Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors","volume":"169","author":"Anforth","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib219","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archderm.141.4.456","article-title":"Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study","volume":"141","author":"Harwood","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib220","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2133.2005.06347.x","article-title":"Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials","volume":"152","author":"Chen","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib221","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/jid.2014.531","article-title":"Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis","volume":"135","author":"Muranushi","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib222","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ijc.29357","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer","volume":"137","author":"Reinau","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.116763_bib223","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/bjd.17938","article-title":"Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia","volume":"181","author":"Pandeya","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib224","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.2011.34.5967","article-title":"Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial","volume":"29","author":"Tang","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116763_bib225","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ajcn\/nqaa267","article-title":"Risk of keratinocyte carcinomas with vitamin D and calcium supplementation: a secondary analysis of a randomized clinical trial","volume":"112","author":"Passarelli","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejca.2026.116763_bib226","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamadermatol.2017.3631","article-title":"Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial","volume":"154","author":"Weinstock","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib227","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125476","article-title":"Skin cancer precursor immunotherapy for squamous cell carcinoma prevention","volume":"4","author":"Rosenberg","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejca.2026.116763_bib228","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib229","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/TP.0000000000002641","article-title":"Interventions to Prevent Nonmelanoma Skin Cancers in Recipients of a Solid Organ Transplant: Systematic Review of Randomized Controlled Trials","volume":"103","author":"Chung","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.ejca.2026.116763_bib230","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029265","article-title":"Behavioural and pharmaceutical interventions for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomised controlled trials","volume":"10","author":"James","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejca.2026.116763_bib231","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamadermatol.2021.3180","article-title":"Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement","volume":"157","author":"Massey","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib232","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jphotobiol.2010.04.001","article-title":"Dermatologic management, sun avoidance and vitamin D status in organ transplant recipients (OTR)","volume":"101","author":"Reichrath","year":"2010","journal-title":"J Photochem Photobio B"},{"issue":"4","key":"10.1016\/j.ejca.2026.116763_bib233","first-page":"19","article-title":"European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.1 Long-term immunosuppression. Late steroid or cyclosporine withdrawal","volume":"17","author":"Transplantation EEGoR","year":"2002","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.ejca.2026.116763_bib234","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2006.07454.x","article-title":"Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness","volume":"155","author":"Ismail","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib235","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/bjd.16836","article-title":"Increase in preventive behaviour by organ transplant recipients after sun protection information in a skin cancer surveillance clinic","volume":"179","author":"Papier","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib236","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10880","article-title":"Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework","volume":"35","author":"Bottomley","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejca.2026.116763_bib237","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116763_bib238","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1440-0960.2002.00613.x","article-title":"Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients","volume":"43","author":"George","year":"2002","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib239","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1067\/S0190-9622(03)01831-0","article-title":"Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin","volume":"49","author":"de Sevaux","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib240","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/DSS.0000000000002423","article-title":"Efficacy and Cost Analysis for Acitretin for Basal and Squamous Cell Carcinoma Prophylaxis in Renal Transplant Recipients","volume":"47","author":"Badri","year":"2021","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib241","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaad.2023.11.034","article-title":"Effectiveness of acitretin for skin cancer prevention in immunosuppressed and nonimmunosuppressed patients: A retrospective cohort study","volume":"90","author":"Bhullar","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib242","first-page":"662","article-title":"Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinoma","volume":"30","author":"Martinez","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib243","first-page":"562","article-title":"Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects","volume":"32","author":"Otley","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib244","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/ijd.15442","article-title":"Is the first-line systemic chemoprevention of nonmelanoma skin cancer nicotinamide or acitretin?","volume":"60","author":"Hoegler","year":"2021","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.ejca.2026.116763_bib245","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bjd.14662","article-title":"A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients","volume":"175","author":"Chen","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib246","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1684\/ejd.2017.3025","article-title":"Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study","volume":"27","author":"Drago","year":"2017","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib247","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMc2303841","article-title":"Nicotinamide for Skin-Cancer Chemoprevention in Transplantation","volume":"388","author":"Schmults","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.116763_bib248","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMoa2203086","article-title":"Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients","volume":"388","author":"Allen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.116763_bib249","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00403-025-04296-7","article-title":"Nicotinamide for secondary keratinocyte carcinoma prevention in solid organ transplant recipients","volume":"317","author":"Hwang","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ejca.2026.116763_bib250","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/CAD.0b013e3282f945aa","article-title":"Capecitabine: an overview of the side effects and their management","volume":"19","author":"Saif","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ejca.2026.116763_bib251","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1399-0012.2010.01348.x","article-title":"Capecitabine for skin cancer prevention in solid organ transplant recipients","volume":"25","author":"Jirakulaporn","year":"2011","journal-title":"Clin Transpl"},{"key":"10.1016\/j.ejca.2026.116763_bib252","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/dsu.12049","article-title":"Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients","volume":"39","author":"Endrizzi","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib253","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamadermatol.2020.2327","article-title":"Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review","volume":"156","author":"Schauder","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib254","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaad.2020.03.127","article-title":"Field cancerization: Treatment","volume":"83","author":"Cornejo","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib255","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13593","volume":"16","author":"Zwald","year":"2016","journal-title":"Am J Transpl J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib256","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ajt.13596","article-title":"Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort","volume":"16","author":"Coghill","year":"2016","journal-title":"Am J Transpl J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib257","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.healun.2018.03.012","article-title":"Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation","volume":"37","author":"Vos","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.ejca.2026.116763_bib258","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaad.2019.09.070","article-title":"Belatacept reduces skin cancer risk in kidney transplant recipients","volume":"82","author":"Wang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib259","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaad.2015.05.029","article-title":"Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)","volume":"73","author":"Asgari","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib260","article-title":"Mammalian target of rapamycin (mTOR) inhibitors and skin cancer risk in nonrenal solid organ transplant recipients: systematic review and meta-analysis","author":"Phan","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib261","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2026.116763_bib262","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamadermatol.2015.5548","article-title":"Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer","volume":"152","author":"Karia","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib263","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/ajt.14238","article-title":"Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients","volume":"17","author":"Krisl","year":"2017","journal-title":"Am J Transpl J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib264","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjd.15950","article-title":"Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients","volume":"177","author":"Blomberg","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib265","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2025.14711","article-title":"Dermatology Scheduling Triage of Transplant Patients and Transplant Candidates to Improve Early Diagnosis and Prevention of Skin Cancer: International Immunosuppression and Transplant Skin Cancer Collaborative Expert Consensus Recommendations","volume":"38","author":"Hirotsu","year":"2025","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejca.2026.116763_bib266","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/ajt.13978","article-title":"Cancer Screening Recommendations for Solid Organ Transplant Recipients: A Systematic Review of Clinical Practice Guidelines","volume":"17","author":"Acuna","year":"2017","journal-title":"Am J Transpl J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib267","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/ajt.14966","article-title":"Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study","volume":"19","author":"Chan","year":"2019","journal-title":"Am J Transpl J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib268","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/tri.13520","article-title":"Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines","volume":"32","author":"Crow","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejca.2026.116763_bib269","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/tri.13493","article-title":"Predicting skin cancer in organ transplant recipients: development of the SUNTRAC screening tool using data from a multicenter cohort study","volume":"32","author":"Jambusaria-Pahlajani","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejca.2026.116763_bib270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jamadermatol.2022.4820","article-title":"External Validation of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) in a Large European Solid Organ Transplant Recipient Cohort","volume":"159","author":"Gomez-Tomas","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib271","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2025.3890","article-title":"Skin Cancer Surveillance Program for Solid Organ Transplant Recipients","author":"Lee","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116763_bib272","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1200\/JOP.2013.000921","article-title":"Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia","volume":"10","author":"Mansfield","year":"2014","journal-title":"J Oncol Pr"},{"key":"10.1016\/j.ejca.2026.116763_bib273","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1080\/10428194.2019.1620941","article-title":"Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival","volume":"60","author":"Ishdorj","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2026.116763_bib274","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1007\/s10620-018-5056-x","article-title":"Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients","volume":"63","author":"Anderson","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejca.2026.116763_bib275","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1600-6143.2009.02997.x","article-title":"Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial","volume":"10","author":"Salgo","year":"2010","journal-title":"Am J Transpl J Am Soc Transpl Am Soc Transpl Surg"},{"key":"10.1016\/j.ejca.2026.116763_bib276","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.116763_bib277","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1200\/JCO.2012.45.6376","article-title":"Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus","volume":"31","author":"Hoogendijk-van den Akker","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116763_bib278","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","article-title":"Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer","volume":"12","author":"Campbell","year":"2012","journal-title":"Am J Transpl J Am Soc Transpl Am Soc Transpl Surg"},{"issue":"5","key":"10.1016\/j.ejca.2026.116763_bib279","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04296.x","article-title":"Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions","volume":"25","author":"Bonerandi","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2026.116763_bib280","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1056\/NEJMoa2502449","article-title":"Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma","volume":"393","author":"Rischin","year":"2025","journal-title":"N Engl J Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:42:13Z","timestamp":1783485733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926005447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":280,"alternative-id":["S0959804926005447"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116763","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention \u2013 Update 2026","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116763"}}